Expands its capabilities to include comprehensive and full-service solutions, encompassing both small and large molecules, biomarkers and novel modalities.
Will support drug development from early clinical studies through regulatory approval with efficient, flexible and streamlined companion diagnostic development.
From complex challenges to innovative solutions, explore how continuous flow technology is transforming drug substance production efficiency and safety.
The addition of Justin McAnear and Jonathan Butler aims to strengthen the Cellares Executive Leadership Team and enable the company’s continued expansion.